mouse monoclonal anti rat endothelial cell antigen 1 reca antibody (Bio-Rad)
Bio-Rad is a verified supplier 
Bio-Rad manufactures this product 
94
Structured Review
Bio-Rad
mouse monoclonal anti rat endothelial cell antigen 1 reca antibody
Mouse Monoclonal Anti Rat Endothelial Cell Antigen 1 Reca Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 462 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+rat+endothelial+cell+antigen+reca+1+antibody/Mouse+anti+Rat+RECA-1/pm40935228-69-13-27
Average 94 stars, based on 462 article reviews
Mouse Monoclonal Anti Rat Endothelial Cell Antigen 1 Reca Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 462 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+rat+endothelial+cell+antigen+reca+1+antibody/Mouse+anti+Rat+RECA-1/pm40935228-69-13-27
Average 94 stars, based on 462 article reviews
mouse monoclonal anti rat endothelial cell antigen 1 reca antibody - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Immunohistochemistry:Article Title: Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats. Article Snippet: .. Immunohistochemistry Immunohistochemical staining for endothelial cells in the retina was performed as previously reported.15,16) Briefly, the retina was separated from the lens, vitreous, and pigment epithelium, and then incubated in blocking solution (5% normal hamster serum) prepared in PBS containing 0.3% Triton X-100 (PBS-T) for 0.5–1 h. The retina was incubated overnight with a 1 : 800 dilution of Immunohistochemical staining:Article Title: Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats. Article Snippet: .. Immunohistochemistry Immunohistochemical staining for endothelial cells in the retina was performed as previously reported.15,16) Briefly, the retina was separated from the lens, vitreous, and pigment epithelium, and then incubated in blocking solution (5% normal hamster serum) prepared in PBS containing 0.3% Triton X-100 (PBS-T) for 0.5–1 h. The retina was incubated overnight with a 1 : 800 dilution of Staining:Article Title: Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats. Article Snippet: .. Immunohistochemistry Immunohistochemical staining for endothelial cells in the retina was performed as previously reported.15,16) Briefly, the retina was separated from the lens, vitreous, and pigment epithelium, and then incubated in blocking solution (5% normal hamster serum) prepared in PBS containing 0.3% Triton X-100 (PBS-T) for 0.5–1 h. The retina was incubated overnight with a 1 : 800 dilution of Incubation:Article Title: Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats. Article Snippet: .. Immunohistochemistry Immunohistochemical staining for endothelial cells in the retina was performed as previously reported.15,16) Briefly, the retina was separated from the lens, vitreous, and pigment epithelium, and then incubated in blocking solution (5% normal hamster serum) prepared in PBS containing 0.3% Triton X-100 (PBS-T) for 0.5–1 h. The retina was incubated overnight with a 1 : 800 dilution of Article Title: Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats. Article Snippet: Retinal arterial tortuosity and venous dilation are hallmarks of plus disease, which is a severe form of retinopathy of prematurity (ROP).. In this study, we examined whether short-term interruption of vascular endothelial growth factor (VEGF) signals leads to the formation of severe ROP-like abnormal retinal blood vessels.. Neonatal rats were treated subcutaneously with the VEGF receptor (VEGFR) tyrosine kinase inhibitors, KRN633 (1, 5, or 10 mg/kg) or axitinib (10 mg/kg), on postnatal day (P) 7 and P8. Article Title: Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity. Article Snippet: A short-term blockade of the vascular endothelial growth factor (VEGF)-mediated pathway in neonatal rats results in formation of severe retinopathy of prematurity (ROP)-like retinal blood vessels.. The present study aimed to examine the role of retinal neurons in the formation of abnormal retinal blood vessels.. Newborn rats were treated subcutaneously with the VEGF receptor tyrosine kinase inhibitor, KRN633 (10mg/kg), or its vehicle (0.5% methylcellulose in water) on postnatal day (P) 7 and P8. Blocking Assay:Article Title: Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats. Article Snippet: .. Immunohistochemistry Immunohistochemical staining for endothelial cells in the retina was performed as previously reported.15,16) Briefly, the retina was separated from the lens, vitreous, and pigment epithelium, and then incubated in blocking solution (5% normal hamster serum) prepared in PBS containing 0.3% Triton X-100 (PBS-T) for 0.5–1 h. The retina was incubated overnight with a 1 : 800 dilution of Marker:Article Title: Role of mammalian target of rapamycin in the formation and progression of retinopathy of prematurity-like vascular abnormalities in neonatal rats. Article Snippet: Retinopathy of prematurity (ROP), a retinal disease that can occur in premature infants, can lead to severe visual impairment.. In this study, we examined the preventive and therapeutic effects of mammalian target of rapamycin complex 1 (mTORC1) inhibition on abnormal retinal blood vessels in a rat model of ROP.. To induce ROP-like vascular abnormalities, rats were subcutaneously treated with KRN633, an inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinase, on postnatal day 7 (P7) and P8. Article Title: Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats. Article Snippet: Retinal arterial tortuosity and venous dilation are hallmarks of plus disease, which is a severe form of retinopathy of prematurity (ROP).. In this study, we examined whether short-term interruption of vascular endothelial growth factor (VEGF) signals leads to the formation of severe ROP-like abnormal retinal blood vessels.. Neonatal rats were treated subcutaneously with the VEGF receptor (VEGFR) tyrosine kinase inhibitors, KRN633 (1, 5, or 10 mg/kg) or axitinib (10 mg/kg), on postnatal day (P) 7 and P8. |